Evidence map›Paper›PMID 41476752›Full record

ReviewMaterials today. Bio2026

PRP-related biomaterials enhance bone and nerve repair.

Han Zhang, Yunnong Luo, Yunmeng Wang, Mengmeng Sun

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Han ZhangDepartment of Orthopedics, The Second Hospital of Jilin University Changchun, 130041, China.
Yunnong LuoDepartment of Orthopedics, The Second Hospital of Jilin University Changchun, 130041, China.
Yunmeng WangDepartment of Otolaryngology, Head and Neck Surgery, Second Hospital, Jilin University, Changchun, 130041, China.
Mengmeng SunDepartment of Thyroid Surgery, The Second Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone and nerve injuries are the most common problems in orthopedic trauma, so orthopedic researchers are committed to studying efficient and economical strategies for repairing bone defects and nerve injuries. Platelet-rich plasma (PRP) is a self-derived blood derivative rich in growth factors and bioactive components, which plays a key role in promoting bone defect repair and nerve regeneration, and can effectively cope with the clinical problem of marginal bone defect with nerve injury. However, the explosive release of growth factors in PRP affects its practical use, and the controllable release of growth factors on demand can effectively enhance its efficiency in bone and nerve repair. In this paper, the application and mechanism of PRP reinforced biomaterials in bone and nerve regeneration are systematically reviewed. In the process of bone regeneration, PRP can promote the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), induce type H angiogenesis, and promote the regeneration of vascularized bone. In the field of nerve repair, PRP can promote the regeneration of peripheral and central nerve injury sites, stimulate the synthesis of new connective tissue and vascular reconstruction, down-regulate pro-inflammatory factors to build anti-inflammatory microenvironment and reduce nerve cell damage.To sum up, this study deeply discussed the mechanism of PRP in bone and nerve repair, and elaborated various advanced multifunctional biomaterials to solve the explosive release problem of PRP in use, providing theoretical basis for the standardized application and clinical transformation of PRP.

Indexed as

AngiogenesisBone repairImmunoregulationNerve repairPlatelet-rich plasmaRegenerative medicine

Identifiers

PMID41476752
PMCPMC12753255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.